John S. March

John S. March's AcademicInfluence.com Rankings

John S. March

Biology

#9891

World Rank

#13153

Historical Rank

biology Degrees

Download Badge

Biology

John S. March's Degrees

Masters Medicine University of Pennsylvania

Why Is John S. March Influential?

(Suggest an Edit or Addition)

(See a Problem?)

John S. March's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. (1999) (3124)
The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity. (1997) (2121)
Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. (2008) (1249)
Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. (2004) (1118)
Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. (2001) (1024)
ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. (2001) (935)
Cognitive assessment of obsessive-compulsive disorder (1997) (872)
Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review. (2004) (628)
3-year follow-up of the NIMH MTA study. (2007) (625)
Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder. (1999) (606)
Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): Implications and Applications for Primary Care Providers (2001) (562)
National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. (2004) (561)
The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes. (2007) (530)
Anxiety disorders in children and adolescents (1995) (503)
Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group. (2001) (453)
The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties. (2002) (449)
Development and natural history of mood disorders (2002) (435)
Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial. (1998) (401)
Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial. (2004) (397)
Test-retest reliability of the Multidimensional Anxiety Scale for Children. (1999) (394)
Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS). (2006) (393)
Observed Classroom Behavior of Children with ADHD: Relationship to Gender and Comorbidity (2002) (374)
National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. (2004) (351)
Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. (2012) (345)
Clinical characteristics of anxiety disordered youth. (2010) (342)
Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I). (2010) (334)
Transdermal nicotine effects on attention (1998) (332)
The Multidimensional Anxiety Scale for Children (MASC). (2004) (324)
Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. (2007) (320)
Child/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods (2010) (318)
Nicotine effects on adults with attention-deficit/hyperactivity disorder (2005) (314)
Cognitive-behavioral psychotherapy for children and adolescents with posttraumatic stress disorder after a single-incident stressor. (1998) (311)
Medication treatment strategies in the MTA Study: relevance to clinicians and researchers. (1996) (287)
Family Processes and Treatment Outcome in the MTA: Negative/Ineffective Parenting Practices in Relation to Multimodal Treatment (2000) (287)
Remission after acute treatment in children and adolescents with anxiety disorders: findings from the CAMS. (2011) (286)
Multimodal treatment of ADHD in the MTA: an alternative outcome analysis. (2001) (284)
Which treatment for whom for ADHD? Moderators of treatment response in the MTA. (2003) (283)
Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial. (2001) (277)
Peer-Assessed Outcomes in the Multimodal Treatment Study of Children With Attention Deficit Hyperactivity Disorder (2005) (265)
Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS). (2006) (249)
National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices. (1997) (249)
Anxiety as a Predictor and Outcome Variable in the Multimodal Treatment Study of Children with ADHD (MTA) (2000) (247)
Multidimensional Anxiety Scale for Children (2012) (244)
Parenting and Family Stress Treatment Outcomes in Attention Deficit Hyperactivity Disorder (ADHD): An Empirical Analysis in the MTA Study (2000) (238)
Behavioral psychotherapy for children and adolescents with obsessive-compulsive disorder: an open trial of a new protocol-driven treatment package. (1994) (229)
Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD). (1996) (225)
Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. (2007) (224)
The case for practical clinical trials in psychiatry. (2005) (219)
Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial. (2011) (217)
OCD in Children and Adolescents: A Cognitive-Behavioral Treatment Manual (1998) (210)
The Treatment of Adolescent Suicide Attempters study (TASA): predictors of suicidal events in an open treatment trial. (2009) (210)
Naturalistic follow-up of youths treated for pediatric anxiety disorders. (2014) (209)
Development and validation of a child version of the obsessive compulsive inventory. (2010) (209)
Psychosocial Treatment Strategies in the MTA Study: Rationale, Methods, and Critical Issues in Design and Implementation (2000) (200)
Predictors and moderators of treatment response in childhood anxiety disorders: results from the CAMS trial. (2014) (197)
Young adult outcomes in the follow‐up of the multimodal treatment study of attention‐deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression (2017) (191)
Tics Moderate Treatment Outcome with Sertraline but not Cognitive-Behavior Therapy in Pediatric Obsessive-Compulsive Disorder (2007) (188)
Recovery and recurrence following treatment for adolescent major depression. (2011) (187)
Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. AACAP. (1998) (185)
Treatment for Adolescents with Depression Study (TADS): safety results. (2006) (178)
Comprehensive assessment of childhood Attention-Deficit Hyperactivity Disorder in the context of a multisite, multimodal clinical trial (1997) (175)
Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA. (2001) (169)
The Treatment for Adolescents with Depression Study (TADS): methods and message at 12 weeks. (2006) (168)
Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder. (2001) (168)
Treatment for Adolescents With Depression Study (TADS): rationale, design, and methods. (2003) (166)
Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD. (2003) (154)
Cognitive-behavioral psychotherapy for children and adolescents with OCD: a review and recommendations for treatment. (1995) (151)
Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial. (2003) (149)
Family-based treatment of early childhood obsessive-compulsive disorder: the Pediatric Obsessive-Compulsive Disorder Treatment Study for Young Children (POTS Jr)--a randomized clinical trial. (2014) (146)
Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses. (2007) (144)
Trajectories of change in youth anxiety during cognitive-behavior therapy. (2015) (140)
Remission and recovery in the Treatment for Adolescents with Depression Study (TADS): acute and long-term outcomes. (2009) (138)
Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder. (2001) (138)
Defining ADHD symptom persistence in adulthood: optimizing sensitivity and specificity (2017) (138)
Posttraumatic symptomatology in children and adolescents after an industrial fire. (1997) (137)
Assessing medication effects in the MTA study using neuropsychological outcomes. (2006) (137)
24- and 36-week outcomes for the Child/Adolescent Anxiety Multimodal Study (CAMS). (2014) (137)
The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up. (2009) (130)
Impact of childhood trauma on treatment outcome in the Treatment for Adolescents with Depression Study (TADS). (2010) (130)
Social phobia and separation anxiety symptoms in community and clinical samples of children and adolescents. (2000) (130)
A Randomized Controlled Trial of Venlafaxine ER Versus Placebo in Pediatric Social Anxiety Disorder (2007) (130)
Adolescents With Depression—Reply (2004) (129)
Predictors of parental accommodation in pediatric obsessive-compulsive disorder: findings from the Pediatric Obsessive-Compulsive Disorder Treatment Study (POTS) trial. (2011) (122)
Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics. (2011) (122)
Racial Differences on the Conners Teacher Rating Scale (1998) (120)
Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders. (2005) (120)
The Child Anxiety Impact Scale: Examining Parent- and Child-Reported Impairment in Child Anxiety Disorders (2014) (118)
Socioeconomic status as a moderator of ADHD treatment outcomes. (2002) (116)
Posttraumatic Stress Disorder in Youth: A Critical Review of the Cognitive and Behavioral Treatment Outcome Literature. (2004) (115)
Suicidal events in the Treatment for Adolescents With Depression Study (TADS). (2009) (115)
Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS). (2006) (115)
Evaluation of a preventive intervention for child anxiety in two randomized attention-control school trials. (2011) (114)
Obsessive-compulsive disorder in children and adolescents: a review of the past 10 years. (1996) (111)
Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity disorder. (2006) (110)
Social problem-solving among adolescents treated for depression. (2010) (108)
Pharmacology of the selective serotonin reuptake inhibitors in children and adolescents. (1997) (104)
Diagnostic Efficiency of the Child and Parent Versions of the Multidimensional Anxiety Scale for Children (2012) (102)
Cognitive-Behavioral Psychotherapy for Pediatric Obsessive-Compulsive Disorder (2001) (101)
Clinical messages from the Treatment for Adolescents With Depression Study (TADS). (2009) (95)
Sertraline in children and adolescents with social anxiety disorder: an open trial. (2001) (93)
Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology. (2004) (88)
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Obsessive-Compulsive Disorder (2012) (87)
Life events and post-traumatic stress: the development of a new measure for children and adolescents (1998) (87)
Asymmetrical hemispheric control of visual-spatial attention in adults with attention deficit hyperactivity disorder. (1997) (87)
NIMH collaborative multimodal treatment study of children with ADHD (MTA): Design, methodology, and protocol evolution (1997) (86)
Empirically derived subtypes of adolescent depression: latent profile analysis of co-occurring symptoms in the Treatment for Adolescents with Depression Study (TADS). (2007) (84)
Assessing Anxiety in Youth with the Multidimensional Anxiety Scale for Children (2014) (84)
Absence of urinary opioid peptides in children with autism (2008) (83)
Cost-effectiveness of treatments for adolescent depression: results from TADS. (2008) (83)
Dysfunctional Attitudes Scale Perfectionism: A Predictor and Partial Mediator of Acute Treatment Outcome among Clinically Depressed Adolescents (2009) (80)
Treatment of pediatric anxiety disorders: an open-label extension of the research units on pediatric psychopharmacology anxiety study. (2002) (80)
Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: preliminary findings. (2001) (80)
Assessment and intervention for attention-deficit/hyperactivity disorder in the schools. Lessons from the MTA study. (1999) (80)
Examining the Psychometric Properties of the Family Accommodation Scale-Parent-Report (FAS-PR) (2011) (79)
Review of safety assessment methods used in pediatric psychopharmacology. (2003) (78)
The role of readiness to change in response to treatment of adolescent depression. (2009) (78)
Defining treatment response and remission in child anxiety: signal detection analysis using the pediatric anxiety rating scale. (2013) (73)
The place of and evidence for serotonin reuptake inhibitors (SRIs) for obsessive compulsive disorder (OCD) in children and adolescents: Views based on a systematic review and meta-analysis (2015) (70)
A Double-Blind, Placebo-Controlled Study of Atomoxetine in Young Children With ADHD (2011) (70)
A double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder. (2014) (70)
An Exploratory Analysis of the Impact of Family Functioning on Treatment for Depression in Adolescents (2009) (70)
Improving attention-deficit/hyperactivity disorder treatment outcomes through use of a collaborative consultation treatment service by community-based pediatricians: a cluster randomized trial. (2007) (68)
Anxiolytics, adrenergic agents, and naltrexone. (1999) (67)
Relative cost-effectiveness of treatments for adolescent depression: 36-week results from the TADS randomized trial. (2009) (66)
Predicting the Outcome of Treatment (1998) (66)
Depressive symptoms and clinical status during the Treatment of Adolescent Suicide Attempters (TASA) Study. (2009) (65)
How can we improve the assessment of safety in child and adolescent psychopharmacology? (2003) (64)
Somatic Complaints in Anxious Youth (2014) (63)
An Effectiveness Study of a Culturally Enriched School-Based CBT Anxiety Prevention Program (2011) (63)
The nosology of posttraumatic stress disorder (1990) (62)
New Developments in Assessing Pediatric Anxiety Disorders (1998) (62)
Depression, anxiety, and functional impairment in children with trichotillomania (2008) (60)
Acute time to response in the Treatment for Adolescents with Depression Study (TADS). (2006) (59)
Searching for moderators and mediators of pharmacological treatment effects in children and adolescents with anxiety disorders. (2003) (59)
The pediatric obsessive-compulsive disorder treatment study: rationale, design, and methods. (2003) (57)
The impact of neuropsychological functioning on treatment outcome in pediatric obsessive–compulsive disorder (2010) (56)
Maternal and Child Expressed Emotion as Predictors of Treatment Response in Pediatric Obsessive–Compulsive Disorder (2012) (55)
Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients. (1990) (55)
Selective serotonin reuptake inhibitors in pediatric depression: is the balance between benefits and risks favorable? (2006) (55)
Parental Anxiety as a Predictor of Medication and CBT Response for Anxious Youth (2015) (55)
The Multidimensional Anxiety Scale for Children (MASC): Confirmatory factor analysis in a pediatric ADHD sample (1999) (55)
BENEFITS OF CHILD‐FOCUSED ANXIETY TREATMENTS FOR PARENTS AND FAMILY FUNCTIONING (2013) (53)
The Pediatric Obsessive-Compulsive Disorder Treatment Study II: rationale, design and methods (2009) (52)
Therapist Factors and Outcomes in CBT for Anxiety in Youth. (2013) (52)
Nine Months of Multicomponent Behavioral Treatment for ADHD and Effectiveness of MTA Fading Procedures (2004) (50)
Teacher Awareness of Anxiety Symptoms in Children (2006) (50)
Psychopharmacology of pediatric posttraumatic stress disorder. (1999) (49)
Cognitive-behavioral therapy for pediatric obsessive-compulsive disorder: Empirical review and clinical recommendations (2015) (48)
A pilot study of atomoxetine in young children with attention-deficit/hyperactivity disorder. (2007) (48)
Onset of alcohol or substance use disorders following treatment for adolescent depression. (2012) (47)
The effects of anxiety on continuous performance test functioning in an ADHD clinic sample (1997) (47)
A double-blind efficacy and safety study of duloxetine flexible dosing in children and adolescents with major depressive disorder. (2014) (47)
Child/Adolescent anxiety multimodal study: evaluating safety. (2015) (47)
The Child and Adolescent Psychiatry Trials Network (CAPTN). (2004) (45)
Treatment of children and adolescents. (2000) (45)
Cognitive-behavioral treatment for pediatric posttraumatic stress disorder: Protocol and application in school and community settings (2003) (44)
Treatment benefit and the risk of suicidality in multicenter, randomized, controlled trials of sertraline in children and adolescents. (2006) (44)
The Dysfunctional Attitudes Scale: Psychometric Properties in Depressed Adolescents (2009) (44)
The future of psychotherapy for mentally ill children and adolescents. (2009) (44)
The therapeutic relationship in cognitive-behavioral therapy and pharmacotherapy for anxious youth. (2013) (42)
A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression. (1990) (42)
The Role of Stimulants in the Treatment of Preschool Children with Attention-Deficit Hyperactivity Disorder (2004) (40)
Developing methodologies for monitoring long-term safety of psychotropic medications in children: report on the NIMH conference, September 25, 2000. (2003) (40)
Treating Depression and Oppositional Behavior in Adolescents (2010) (39)
Obsessive compulsive disorder in children and adolescents: The role of the school psychologist in identification, assessment, and treatment. (1994) (38)
Predictors of Hopelessness Among Clinically Depressed Youth (2009) (38)
Is parental report of upper respiratory infection at the onset of obsessive-compulsive disorder suggestive of pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection? (2002) (37)
Assessment issues in treatment research of pediatric anxiety disorders: what is working, what is not working, what is missing, and what needs improvement. (1998) (36)
The Pediatric Obsessive Compulsive Disorder Treatment Study for Young Children (POTS jr): Developmental Considerations in the Rationale, Design, and Methods. (2012) (36)
Treatment of Attention-Deficit/Hyperactivity Disorder: Expert Consensus Guidelines (2000) (35)
Assessment of safety and long-term outcomes of initial treatment with placebo in TADS. (2009) (35)
Treatment response in depressed adolescents with and without co-morbid attention-deficit/hyperactivity disorder in the Treatment for Adolescents with Depression Study. (2009) (34)
Absence of cardiovascular adverse effects of sertraline in children and adolescents. (1999) (34)
An assessment of the adequacy of self-care by adult asthmatics (1980) (33)
Child and adolescent psychopharmacology in the new millennium: a workshop for academia, industry, and government. (2006) (31)
Depressed Adolescents and Comorbid Psychiatric Disorders: Are There Differences in the Presentation of Depression? (2008) (31)
A manual-based intervention to address clinical crises and retain patients in the Treatment of Adolescents With Depression Study (TADS). (2007) (31)
AACAP 2002 research forum: placebo and alternatives to placebo in randomized controlled trials in pediatric psychopharmacology. (2004) (30)
Ethnic differences among adolescents beginning treatment for depression. (2010) (28)
Comorbidity of Childhood and Adolescent Anxiety Disorders (2004) (28)
Achievement and maintenance of sustained response during the Treatment for Adolescents With Depression Study continuation and maintenance therapy. (2008) (28)
Response to Commentary on the Multimodal Treatment Study of ADHD (MTA): Mining the Meaning of the MTA (2002) (27)
Emotional well-being in children and adolescents treated with atomoxetine for attention-deficit/hyperactivity disorder: Findings from a patient, parent and physician perspective using items from the pediatric adverse event rating scale (PAERS) (2008) (27)
Manualized cognitive-behavioral psychotherapy for obsessive-compulsive disorder in childhood: A preliminary single case study☆ (1995) (26)
Findings From the Treatment for Adolescents with Depression Study (TADS): What Have We Learned? What Do We Need to Know? (2009) (26)
An open-label safety and pharmacokinetics study of duloxetine in pediatric patients with major depression. (2012) (24)
Ethnic Differences in Attributions and Treatment Expectancies for Adolescent Depression. (2008) (24)
Are increased weight and appetite useful indicators of depression in children and adolescents? (2012) (24)
Anxiety Disorders in Caucasian and African American Children: A Comparison of Clinical Characteristics, Treatment Process Variables, and Treatment Outcomes (2015) (24)
Does multimodal treatment of ADHD decrease other diagnoses? (2005) (24)
What Have We Learned about Trial Design From NIMH-Funded Pragmatic Trials? (2010) (24)
Factors associated with recruitment and screening in the Treatment for Adolescents With Depression Study (TADS). (2007) (23)
Fluoxetine and fluvoxamine in PTSD. (1992) (23)
Does Homework “Matter” in Cognitive Behavioral Therapy for Adolescent Depression? (2012) (23)
Do subtle neurological impairments predict treatment resistance to clomipramine in children and adolescents with obsessive-compulsive disorder? (1990) (23)
The ethical use of placebo in clinical trials involving children. (2004) (23)
The evidence-based pharmacological treatment of paediatric ADHD. (2012) (23)
Acute stress disorder in youth: a multivariate prediction model (2003) (23)
A probabilistic and individualized approach for predicting treatment gains: an extension and application to anxiety disordered youth. (2014) (22)
AACAP 2005 Research Forum: speeding the adoption of evidence-based practice in pediatric psychiatry. (2007) (22)
Using and teaching evidence-based medicine: the Duke University child and adolescent psychiatry model. (2005) (22)
SSRI-induced mania. (1996) (21)
Behavioral avoidance test for childhood obsessive-compulsive disorder: a home-based observation. (2003) (21)
Service Use and Costs of Care for Depressed Adolescents: Who Uses and Who Pays? (2009) (20)
Treatment of pediatric obsessive-compulsive disorder: A case example of intensive cognitive-behavioral therapy involving exposure and ritual prevention (2001) (19)
Factor Structure and Psychometric Properties of the Children's Negative Cognitive Error Questionnaire with a Clinically Depressed Adolescent Sample (2009) (18)
The child and adolescent psychiatry trials network (CAPTN): infrastructure development and lessons learned (2009) (18)
Emergency/Adjunct services and attrition prevention for randomized clinical trials in children: the MTA manual-based solution. (2002) (18)
Advances in the Pharmacotherapy of Attention-Deficit/Hyperactivity Disorder (2007) (17)
Editorial: Developmental neuroscience comes of age. (2011) (17)
Obsessive-Compulsive Disorder in Childhood and Adolescence: Description and Treatment (2007) (17)
Combining medication and psychosocial treatments: an evidence-based medicine approach (2002) (17)
Looking to the future of research in pediatric anxiety disorders (2011) (16)
Pharmacotherapy for anxiety disorders in children and adolescents: an evidence-based medicine review. (2007) (16)
Pharmacotherapy of Obsessive-Compulsive Disorder (1995) (15)
Neuropsychiatry of obsessive-compulsive disorder in children and adolescents. (1995) (15)
Research knowledge among the participants in the Treatment for Adolescents With Depression Study (TADS). (2007) (15)
Cognitive Measures of Adolescent Depression: Unique or Unitary Constructs? (2009) (15)
Adaptive treatment strategies for children and adolescents with Obsessive-Compulsive Disorder: A sequential multiple assignment randomized trial. (2018) (14)
Predicting Anxiety Diagnoses and Severity with the CBCL-A: Improvement Relative to Other CBCL Scales? (2015) (14)
Integrated Psychosocial and Pharmacological Treatment (2004) (13)
Serotonin and treatment in obsessive-compulsive disorder. (1989) (12)
Improving the methods for evaluating the safety of psychotropic medications in children and adolescents (2001) (12)
Attention Bias Modification Training and the New Interventions Research (2010) (12)
Benefits Exceed Risks of Newer Antidepressant Medications in Youth—Maybe (2009) (12)
Acute and longer-term safety results from a pooled analysis of duloxetine studies for the treatment of children and adolescents with major depressive disorder. (2015) (11)
Kundalini Yoga Meditation Versus the Relaxation Response Meditation for Treating Adults With Obsessive-Compulsive Disorder: A Randomized Clinical Trial (2019) (11)
Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infection (PANDAS): implications for clinical practice. (2004) (10)
Extreme thinking in clinically depressed adolescents: Results from the Treatment for Adolescents with Depression Study (TADS). (2010) (10)
Anxiety disorders in children and adolescents: Neuropsychiatry of paediatric anxiety disorders (2000) (10)
Summary of the practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. American Academy of Child and Adolescent Psychiatry. (1998) (10)
It Is Time to Take a Stand for Medical Research and Against Terrorism Targeting Medical Scientists (2008) (9)
EFFECTIVE TREATMENT OF OCD?: In Reply (2006) (9)
A multisite psychotherapy and medication trial for depressed adolescents: Background and benefits (2005) (9)
Comparative efficacy of cognitive behavioral therapy, fluoxetine, and their combination in depressed adolescents: Initial lessons from the treatment for adolescents with depression study (2005) (9)
The preschool ADHD Treatment Study (PATS) as the culmination of twenty years of clinical trials in pediatric psychopharmacology. (2011) (8)
Mutations in sphingolipid metabolism genes are associated with ADHD (2020) (8)
Drug development in pediatric psychiatry: current status, future trends (2012) (8)
Cognitive Aspects of Obsessive Compulsive Disorder in Children (2002) (7)
Predicting antipsychotic use in children. (2007) (7)
Advances in paediatric neuropsychopharmacology: an overview. (2001) (7)
Authors of TADS study reply to letter raising concerns (2005) (7)
Parental Marital Discord and Treatment Response in Depressed Adolescents (2011) (7)
Pharmacotherapy of childhood anxiety disorders (2002) (6)
Pharmacotherapy of Pediatric Anxiety Disorders (1999) (6)
OBSESSIVE COMPULSIVE COGNITIONS WORKING GROUP* (2003) (6)
Multimodality Therapies: Methodologie Issues in Research and Practice (1994) (5)
Banishing OCD: Psychotherapy for cognitive-behavioral obsessive-compulsive disorders. (1996) (5)
Combining Pharmacotherapy and Psychotherapy: An Evidence-based Approach (2010) (5)
An evidence-based medicine approach to combined treatment for ADHD in children and adolescents. (2003) (5)
Tyrosyl Kinase Activity Is Inversely Related to Prostatic Acid Phosphatase Activity in Two Human Prostate Carcinoma Cell Lines (2003) (5)
77-3 A placebo-controlled trial of sertraline treatment for pediatric obsessive compulsive disorder (1997) (4)
Still Struggling: Characteristics of Youth With OCD Who are Partial Responders to Medication Treatment (2011) (4)
DISTINGUISHING ANXIETY DISORDERS PSYCHOMETRICALLY (1997) (4)
Pharmacological management of treatment-resistant pediatric depression. (2005) (4)
Treating Obsessive-Compulsive Disorder in Children and Adolescents. (2007) (4)
Clinical practice guidelines. (2007) (3)
with autism Absence of urinary opioid peptides in children (2008) (3)
Sleep disturbance in PTSD. (1990) (3)
Review: clomipramine is more effective than SSRIs for paediatric obsessive compulsive disorder (2004) (3)
Fluoxetine-TCA interaction. (1990) (3)
Case report: high plasma level tricyclic antidepressant therapy in children: a case report and commentary. (1993) (2)
MANIA IN CHILDREN WITH PDD (1997) (2)
Practical child and adolescent psychopharmacology: Obsessive–compulsive disorder (2002) (2)
Sertraline reduced the severity of patients’ depressive symptoms in major depressive disorder (2004) (2)
Placebo use. Author's reply (2005) (2)
Commentary on 'Forum: use of antidepressants in children and adolescents'. (2010) (1)
Imipramine plus cognitive behavioural therapy (CBT) was more effective than placebo plus CBT in adolescents with comorbid anxiety and depression who refused to attend school (2000) (1)
Children and Violence (1994) (1)
P.3.007 Safety and efficacy of venlafaxine ER in the treatment of pediatric social anxiety disorder (2004) (1)
Pediatric Obsessive-Compulsive Disorder (2004) (1)
Cognitive Behavioural Therapy in Obsessive‐Compulsive Disorder: State of the Art (2012) (1)
ASSESSMENT AND INTERVENTION FOR HYPERACTIVITY DISORDER IN THE SCHOOLS ATTENTION-DEFICIT/ (1999) (1)
CBT VERSUS SUPPORTIVE THERAPY FOR DEPRESSION (2005) (1)
1 Evidence-based pharmacotherapy of attention deficit hyperactivity disorder (2015) (0)
CBT plus parental anxiety management was more effective when the child and parent(s) were anxious (1999) (0)
Obsessive Compulsive Inventory--Child Version (2012) (0)
Faculty of 1000 evaluation for Annual Research Review: New frontiers in developmental neuropharmacology: can long-term therapeutic effects of drugs be optimized through carefully timed early intervention? (2011) (0)
Parental Anxiety as a Predictor of Medication and CBT Response for Anxious Youth (2014) (0)
Adolescents with depression. Authors' reply (2004) (0)
CBT versus supportive therapy for depression. Authors' reply (2005) (0)
Faculty Opinions recommendation of Attention bias modification treatment: a meta-analysis toward the establishment of novel treatment for anxiety. (2011) (0)
Research Forum: Advancing Biomarker Sciences in Pediatric Psychiatry (2011) (0)
Perils in Psychiatric Drug Development (2010) (0)
TADS critiques lack scientific rigor, accuracy and thus credibility (2017) (0)
Tailoring Treatment to Parental Values: A Comment on TADS—Reply (2008) (0)
Maternal and Child Expressed Emotion as Predictors of Treatment Response in Pediatric Obsessive–Compulsive Disorder (2011) (0)
Cognitive Behaviour Therapy for Children and Families: Cognitive behavioural psychotherapy for obsessive compulsive disorders (2004) (0)
In Memoriam: Elizabeth Weller, M.D. (2010) (0)
Predicting Anxiety Diagnoses and Severity with the CBCL-A: Improvement Relative to Other CBCL Scales? (2014) (0)
Children's Negative Cognitive Error Questionnaire--Adaptation for Depressed Adolescents (2015) (0)
TOWARD A RATIONAL PRESCRIBING PRACTICE (1996) (0)
Multidimensional Anxiety Scale for Children--Portuguese Version (2019) (0)
189. Pediatric psychopharmacology: NIMH-sponsored multisite studies (2000) (0)
CBT: An Important Part of Treatment (2005) (0)
Bibliography C HILD A ND A DOLESCENT P SY C HIA T RY (2004) (0)
Evidence-based pharmacotherapy of attention deficit hyperactivity disorder (2012) (0)
Trastorno por estrés postraumático infantil (2006) (0)
Cognitive Behavior Therapy for Pediatric Obsessive-Compulsive Disorder—Reply (2012) (0)
Somatic Complaints in Anxious Youth (2013) (0)
In Memory of Richard Todd (2008) (0)
SPECIAL SECTION: FINDINGS FROM THE TREATMENT FOR ADOLESCENTSWITH DEPRESSIONSTUDY (TADS) (2009) (0)
Anxiety Disorders in Caucasian and African American Children: A Comparison of Clinical Characteristics, Treatment Process Variables, and Treatment Outcomes (2014) (0)
A Randomized Phase II Study of Pemetrexed in Combination With Cisplatin or Carboplatin as First-Line Therapy for Patients With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (2013) (0)
Review: a pooled long term persistence rate of 40% for childhood OCD is lower than previously expected (2005) (0)
Report From the National Advisory Mental Health Council Workgroup on Interventions Research (2010) (0)
Pediatric Anxiety Rating Scale (2002) (0)
Family Accommodation Scale–-Parent Report; 12-Item Version (2020) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With John S. March?

John S. March is affiliated with the following schools:

Duke University